GMP AI Risk Assessment Template
Overview
This GMP AI Risk Assessment Template provides a structured, ready-to-use checklist for evaluating artificial intelligence tools being considered for use in GMP-regulated pharmaceutical environments. It is designed to help quality assurance professionals, validation engineers, and compliance teams systematically assess AI-related risks before implementation.
Who Is This For?
- Pharmaceutical Quality Assurance professionals
- Validation Engineers (CSV/CSA practitioners)
- Regulatory Affairs and Compliance teams
- IT and Digital Transformation leads in GxP environments
- Quality Management System owners
- Anyone evaluating AI tools for use in regulated manufacturing
Use Cases
- Initial risk assessment before deploying AI in GMP operations
- Change control impact assessments involving AI tools
- Supplier qualification of AI software vendors
- Internal audits of AI system governance
- Regulatory inspection preparation for AI-enabled systems
- GAMP 5 categorization and validation planning for AI
Download
The template is available in both editable Word format and PDF for printing or reference.
Key Benefits
- Structured approach: Covers all critical risk dimensions including data integrity, validation, regulatory compliance, and operational impact
- GMP-aligned: Built around 21 CFR Part 11, EU GMP Annex 11, GAMP 5, and ICH Q9 expectations
- Practical: Ready to use immediately — no complex setup or customization required
- Flexible: Editable DOCX format allows adaptation to your specific QMS and SOPs
- Audit-ready: Produces documented risk assessment evidence suitable for regulatory inspection
What the Template Covers
- AI system classification and intended use
- Data integrity and ALCOA+ compliance considerations
- 21 CFR Part 11 electronic records and signatures assessment
- Validation approach (IQ/OQ/PQ or CSA-based)
- Change control and lifecycle management
- Supplier and vendor qualification factors
- Risk scoring and mitigation planning
- Regulatory and compliance gap identification
Related Articles
- AI for Pharmaceutical Risk Management Under ICH Q9
- Computer System Validation for AI Software
- Validating AI Systems in Pharma
- 21 CFR Part 11 and AI in Pharmaceutical Systems
- AI and Change Control Risk Assessment
- AI and Data Integrity: Enforcing ALCOA+ in Pharmaceutical Systems
- AI for Equipment Qualification (IQ, OQ, PQ)
Disclaimer
This template is provided for educational and informational purposes only. It does not constitute regulatory advice, legal guidance, or a validated quality system document. Organizations should adapt this template to their specific regulatory requirements, quality management systems, and internal SOPs. Always consult with qualified regulatory and quality professionals before making compliance decisions.